i)We do not treat patients depend on the phenotype of the tumor varies whether it is a BRCA1 (mainly TNBC) or a BRCA2 (mainly HR positive) mutations; ii) Adjuvant therapy is a standard systemic treatment and depends on tumor stage, grade, and molecular subtypes, but not gene mutation variants. Here, BRCA2 is linked to neoplasm.